Cargando…
Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous system. At present, the molecular mechanisms causing the initiation, development and progression of MS are poorly understood, and no reliable proteinaceous disease markers are available. In this study,...
Autores principales: | Colomba, Paolo, Fontana, Simona, Salemi, Giuseppe, Barranca, Marilisa, Lo Sicco, Claudia, Mazzola, Maria Antonietta, Ragonese, Paolo, Savettieri, Giovanni, De Leo, Giacomo, Alessandro, Riccardo, Duro, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284765/ https://www.ncbi.nlm.nih.gov/pubmed/25517032 http://dx.doi.org/10.3390/ijms151223269 |
Ejemplares similares
-
Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Composition of Extracellular Vesicles in Cerebrospinal Fluid
por: Geraci, Fabiana, et al.
Publicado: (2018) -
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study
por: Ragonese, Paolo, et al.
Publicado: (2017) -
Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients
por: Salemi, Giuseppe, et al.
Publicado: (2010) -
Teaching Research Methods to Young Neurologists: The Erice International Courses
por: Rocca, Walter A., et al.
Publicado: (2022) -
Evaluation of serum and cerebrospinal fluid biomarkers after vaccination against SARS‐CoV‐2
por: Iacono, Salvatore, et al.
Publicado: (2023)